Envista Holdings Corp. (NVST)
21.78
-0.12
(-0.57%)
USD |
NYSE |
Dec 17, 15:56
Envista Holdings Research and Development Expense (Annual): 99.10M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| West Pharmaceutical Services, Inc. | 69.10M |
| Align Technology, Inc. | 364.20M |
| Dentsply Sirona, Inc. | 165.00M |
| Abbott Laboratories | 2.823B |
| Milestone Scientific, Inc. | 0.8588M |